What are Astrana Health's profit margins?

Gross margin is 10.7% and operating margin is 2.5%, with a 0.9% net margin.

Where does Astrana Health's income statement data come from?

Every line is extracted from Astrana Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Astrana Health ASTH Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$3.18B+56.4%	$2.03B+46.7%	$1.39B+21.2%	$1.14B+47.8%
Total cost of revenue	$2.84B+61.1%	$1.76B+50.5%	$1.17B+24.0%	$944.69M+58.5%
Gross profit	$341.53M+25.8%	$271.39M+26.3%	$214.96M+7.8%	$199.48M+12.2%
Gross margin	10.7%-2.6pp	13.3%-2.2pp	15.5%-1.9pp	17.4%-5.5pp
General and administrative	$217.26M+41.0%	$154.11M+36.9%	$112.6M+45.0%	$77.67M+25.1%
Compensation and benefits	——	——	——	——
Occupancy and equipment	——	——	——	——
Depreciation and amortization	$45.75M+63.8%	$27.93M+57.4%	$17.75M+1.2%	$17.54M+0.1%
Goodwill impairment	——	——	——	——
Total costs & expenses	$3.1B+59.5%	$1.95B+49.4%	$1.3B+25.2%	$1.04B+53.9%
Operating income	$78.53M-12.1%	$89.35M+1.0%	$88.49M-15.1%	$104.26M+6.2%
Operating margin	2.5%-1.9pp	4.4%-2.0pp	6.4%-2.7pp	9.1%-3.6pp
Interest expense	$49.93M+50.9%	$33.1M+106%	$16.1M+103%	$7.92M+46.8%
Interest income	$12.16M-16.2%	$14.51M+2.1%	$14.21M+619%	$1.98M+25.7%
Other income (expense), net	-$38.92M-356%	-$8.53M-263%	$5.22M+130%	-$17.65M+13.6%
Income before income taxes	$39.61M-52.1%	$82.71M-7.9%	$89.84M+3.7%	$86.62M—
Income tax expense	$15.53M-49.7%	$30.89M-3.5%	$31.99M-21.7%	$40.87M+29.0%
Net income	$22.49M—	——	$60.72M+34.4%	$45.17M-34.5%
Net margin	0.7%—	——	4.4%+0.4pp	3.9%-5.0pp
Net income attributable to noncontrolling interests	——	——	——	——
Diluted earnings per share	$0.47—	——	$1.29+31.6%	$0.98-35.1%
Basic earnings per share	$0.46—	——	$1.29+26.5%	$1.02-35.0%
Weighted-average shares, diluted	——	——	——	——
Weighted-average shares, basic	——	——	——	——
Depreciation and amortization	$45.75M+63.8%	$27.93M+57.4%	$17.75M+1.2%	$17.54M+0.1%
Amortization Of Financing Costs	$4.05M+122%	$1.83M+72.3%	$1.06M+13.0%	$939K-12.9%
Amortization of capitalized software and acquired intangible assets	——	——	——	——
Stock options excluded as their inclusion would be anti-dilutive (in shares)	——	——	——	——
Business Acquisition Pro Forma Earnings Per Share Basic	——	——	——	——
Business Acquisition Pro Forma Earnings Per Share Diluted	——	——	——	——
Business Acquisitions Pro Forma Net Income Loss	——	——	——	——
Business Acquisitions Pro Forma Revenue	——	——	——	——
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	——	——	——	——
Change In Fair Value Of Contingent Consideration Liabilities	——	——	——	——
Changes In Operating Assets And Liabilities Net Of Business Combinations	——	——	——	——
Effective interest rate	——	——	——	——
Deferred and other income taxes	——	——	-$12.44M+12.8%	-$14.28M—
Effective tax rates	——	——	——	——
Equity method investment, impairment	——	——	——	——
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings	——	——	——	——
Goodwill impairment losses	——	——	——	——
Purchase Price Adjustments	——	——	——	——
Impairment of intangible assets	——	——	——	——
Income taxes paid	——	$43.94M-22.3%	$56.57M+19.6%	$47.31M+27.2%
Income Taxes Paid, Net	——	——	——	——
Add - Incremental shares associated with contingently issuable shares (in shares)	——	——	——	——
Interest Paid, Excluding Capitalized Interest, Operating Activity	$45.77M+50.5%	$30.42M+113%	$14.25M+114%	$6.67M+60.5%
Lease Cost	——	——	——	——
Current year	——	——	——	——
Liability for Unpaid Claims and Claims Adjustment Expense, Incurred Claims	——	——	——	——
Liability for Unpaid Claims and Claims Adjustment Expense, Business Acquisitions	——	——	——	——
Prior years	——	——	——	——
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid For Acquired Balance	——	——	——	——
Minority Interest Decrease From Redemptions	——	——	——	——
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	$595.68M—	——	$3.42M—	——
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$539M-180%	-$192.4M-194%	-$65.52M—	——
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$117.48M—	——	$68.23M-16.9%	$82.13M—
Net Income Loss Attributable To Noncontrolling Interest	——	——	——	——
Net Income Loss Including Portion Attributable To Noncontrolling Interest And Temporary Equity	——	——	——	——
Non Cash Dividend Paid In Form Of Stock	——	$0—	$0—	——
Noncash Lease Expense	——	——	——	——
Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders And Stock Repurchased During Period Value Release Of Hold Back Shares	——	——	——	——
Number of reportable segments	——	——	——	——
Operating Lease Payments	——	——	——	——
Other income, net (Note 6)	——	$4.88M-20.4%	$6.12M+55.2%	$3.95M—
Payment For Repurchase Of Treasury Stock Financing Activities	——	——	——	——
Liability for Unpaid Claims and Claims Adjustment Expense, Claims Paid	——	——	——	——
Payment for (Proceeds from) Other Investing Activity	-$6.32M—	——	$3.68M—	——
Payments of Debt Issuance Costs	——	$0-100%	$3.93M—	——
Payments of Ordinary Dividends, Common Stock	$7.89M+95.4%	$4.04M-93.5%	$62.07M+342%	$14.03M-54.9%
Payment, Tax Withholding, Share-Based Payment Arrangement	$6.17M+32.3%	$4.66M—	——	$0—
Payments to Acquire Property, Plant, and Equipment	$10.11M+25.8%	$8.03M-71.8%	$28.53M+24.4%	$22.94M+19.3%
Potentially Dilutive Securities Contingently Issuable Shares	——	——	——	——
Issuance of debt	——	$171.88M-39.6%	$284.53M—	——
Financing — other	$2.31M—	——	$769K—	——
Proceeds Payments From Other Operating Activities	——	——	——	——
Repayments of Debt	——	$18.5M-91.0%	$204.68M—	——
Revenue From Contract With Customer Excluding Assessed Tax	$3.18B+56.4%	$2.03B+46.7%	$1.39B+21.2%	$1.14B+47.8%
Right Of Use Asset Obtained In Exchange For Operating Lease Liability	$11.88M-15.9%	$14.12M-43.8%	$25.12M—	——
Stock-based compensation	$38.6M+11.8%	$34.54M+56.7%	$22.04M+36.9%	$16.1M+139%
Shares Issued For Vesting Of Restricted Stock Awards	——	——	——	——
Stock Issued During Period Shares Merger	——	——	——	——
Stock issued for employee stock purchase plan	——	——	——	——
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture	——	——	——	——
Stock Issued During The Period Value Cash And Exercise Of Option And Warrants	——	——	——	——
Stock Repurchased During Period Shares	——	——	——	——
Prior years	——	——	——	——
Current year	——	——	——	——
Number of shares purchased (in shares)	——	——	——	——
Total Purchase Price	——	——	——	——
EBIT	$78.53M-12.1%	$89.35M+1.0%	$88.49M-15.1%	$104.26M+6.2%
EBITDA	$124.28M+6.0%	$117.28M+10.4%	$106.23M-12.8%	$121.81M+5.3%
EBITDA	$124.28M+6.0%	$117.28M+10.4%	$106.23M-12.8%	$121.81M+5.3%
EBITDA margin	3.9%-1.9pp	5.8%-1.9pp	7.7%-3.0pp	10.6%-4.3pp
EBIT	$78.53M-12.1%	$89.35M+1.0%	$88.49M-15.1%	$104.26M+6.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Astrana Health's profit margins?: Gross margin is 10.7% and operating margin is 2.5%, with a 0.9% net margin.
Where does Astrana Health's income statement data come from?: Every line is extracted from Astrana Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.